Lung cancer trial reveals 40% drop in deaths using biomarker testing
New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...
aha.org1d
Innovative biopsy technique leads to early lung cancer detection and recovery
“Bev has significant kyphoscoliosis (curvature of the spine that’s both sideways and forward/backward), which made the biopsy ...
Eureka Magazine1d
Researchers develop new inhalable lung cancer therapeutics based on mussels
Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.
News Medical1d
Lung cancer deaths decrease globally but risk factors still persist
Even though lung and related cancer deaths decreased in the world's 10 most populous countries from 1990 to 2019, these positive statistics do not address trends in mortality linked to tobacco use, ...
Science Daily1d
A new turning point in lung cancer treatment, inspired by mussels
Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.
technologynetworks1d
Lung Cancer Therapy Delivery System Inspired by Mussels Developed
A collaborative team has created inhalable mucoadhesive protein nanoparticles inspired by mussel adhesive properties. These ...
Inhalable therapy uses mussel-inspired nanoparticles to target lung cancer cells
Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...
Lung cancer symptoms to look out for in a chesty cough
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
ORACLE lung cancer test predicts survival in early stages better than current methods
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can ...
TMCnet3d
DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
BALTIMORE and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection ...